These findings, together with reports associating mutations in the SCN5A gene (coding for the cardiac Nav1.5 channel) with cardiomyopathy (e.g. [14], [15]), strongly suggest that aberrant Nav1.5 channel expression and function should be considered as potential underlying mechanisms for cardiomyopathy. This evidence concerns the gene SCN5A and cardiomyopathy.